Galdu-irabazien kontua
CITIUS PHARMACEUTICALS, INC.
CTXR
Errendimenduaren laburpena
Egin klik taulako edozein lerrotan grafikoan gehitzeko
milioika USDtan
| Neurria | Sep 30, 2025 2025 FY | Sep 30, 2024 2024 FY | Sep 30, 2023 2023 FY | Sep 30, 2022 2022 FY | Sep 30, 2021 2021 FY | Sep 30, 2020 2020 FY | Sep 30, 2019 2019 FY | Sep 30, 2018 2018 FY | Sep 30, 2017 2017 FY | Sep 30, 2016 2016 FY | Sep 30, 2015 2015 FY | Sep 30, 2013 2013 FY | Sep 30, 2012 2012 FY | Sep 30, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Diru-sarrerak
|
- | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 |
|
Diru-sarreren kostua
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Irabazi gordina
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ustiapen-gastuak
|
38.53 | 42.00 | 36.73 | 33.32 | 23.53 | 17.71 | 15.60 | 13.79 | 9.99 | 7.45 | 3.23 | 0.03 | 0.02 | 0.04 |
|
Ikerketa eta garapena
|
9.16 | 40.00 | 14.82 | 17.66 | 12.24 | 8.81 | 8.60 | 6.56 | 2.94 | 2.93 | 1.80 | - | - | - |
|
Salmentak, orokorrak eta administratiboak
|
18.53 | 18.25 | 15.30 | 11.75 | 9.84 | 8.09 | 6.29 | 6.45 | 6.06 | 3.78 | 0.95 | 0.00 | 0.00 | 0.01 |
|
Beste ustiapen-gastu batzuk
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ustiapen-irabaziak
|
-38.53 | -42.00 | -36.73 | -33.32 | -23.53 | -17.71 | -15.60 | -13.79 | -9.99 | -7.45 | -3.23 | -0.03 | -0.02 | -0.04 |
|
Ez-ustiapeneko diru-sarrerak
|
-0.16 | 3.15 | 4.77 | -0.25 | 0.48 | 0.16 | 0.04 | 1.25 | -0.40 | -0.85 | 0.33 | 0.00 | 0.00 | 0.00 |
|
Interesen diru-sarrerak
|
0.11 | 0.76 | 1.18 | 0.25 | 0.26 | 0.07 | 0.05 | - | - | - | - | - | - | - |
|
Interesen gastuak
|
0.05 | - | - | - | 0.01 | 0.02 | 0.02 | 0.02 | 0.85 | 0.01 | 0.01 | 0.00 | 0.00 | - |
|
Beste ez-ustiapeneko diru-sarrerak/gastuak
|
- | - | - | - | - | - | - | - | - | 0.46 | 0.35 | - | - | - |
|
Zerga aurreko irabazia
|
-38.68 | -38.85 | -31.97 | -33.06 | - | -17.55 | 15.56 | -12.54 | -10.38 | -8.30 | -2.90 | -0.03 | -0.02 | -0.03 |
|
Zerga-gastua
|
1.06 | 0.58 | 0.58 | 0.58 | - | 0.00 | 31.12 | 0.00 | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
|
Partaidetza ez-kontrolatzailea
|
-2.31 | -0.29 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Irabazi garbia
|
-39.74 | -39.43 | -32.54 | -33.64 | -23.05 | -17.55 | -15.56 | -12.54 | 10.38 | 8.30 | -2.90 | -0.03 | -0.02 | -0.04 |
Informazio osagarria
Akzioko datuak, eratorritakoak eta bestelakoak — ez dira galdu-irabazien kontuaren parte
milioika USDtan, bestela adierazi ezean
| Neurria | Sep 30, 2025 2025 FY | Sep 30, 2024 2024 FY | Sep 30, 2023 2023 FY | Sep 30, 2022 2022 FY | Sep 30, 2021 2021 FY | Sep 30, 2020 2020 FY | Sep 30, 2019 2019 FY | Sep 30, 2018 2018 FY | Sep 30, 2017 2017 FY | Sep 30, 2016 2016 FY | Sep 30, 2015 2015 FY | Sep 30, 2013 2013 FY | Sep 30, 2012 2012 FY | Sep 30, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Amortizazioa eta balio-galera
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-38.53 | -42.00 | -36.73 | -33.32 | -23.53 | -17.71 | -15.60 | -13.79 | -9.99 | -7.45 | -3.23 | -0.03 | -0.02 | -0.04 |
|
Akzioko irabazia (oinarrizkoa)
|
-3.38 | -5.97 | - | -0.23 | - | - | - | - | - | - | - | 0.00 | 0.00 | - |
|
EPS diluitua
|
-3.38 | -5.97 | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 | - |
|
Akzioen batez besteko haztatua
|
11.07 | 6.73 | 151.29 | 146.08 | - | - | - | - | - | - | - | 18.00 | 18.00 | - |
|
Akzioen batez besteko haztatu diluitua
|
11.07 | 6.73 | - | - | - | - | - | - | - | - | - | 18.00 | 18.00 | - |
|
Irabazi globala
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |